Dr Nicole Tsim wins young ophthalmologists writing competition
Dr Nicole Tsim is the winner of the 2013 John Henahan Prize. Dr Tsim received her prize from ESCRS president Peter Barry at the Video Awards Session.
After the ceremony, Emanuel Rosen, chairman of the John Henahan Prize Judging Panel, congratulated Dr Tsim and said her essay, written on the theme “Recollections of My First Intraocular Surgery” was outstanding. The Judging Panel, was chaired by Dr Rosen, chairman of the ESCRS Publications Committee.
“In Nicole Tsim’s award-winning essay she liked drawing analogies with several sports where errors can easily creep in if composure is not maintained,” said Dr Rosen. “She also likens her first ECCE experience to a pilot flying solo for the first time where, as she admits, disaster is always just around the corner. Her determination to control her hands and her breathing help us all to recall those first steps in undertaking intraocular surgery trying to banish negative thoughts and concentrate on having a positive attitude.”
Tags: intraocular pressure, optical coherence tomography
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.